Roche has received the CE mark certification for its newly updated cobas 6800/8800 systems 2.0, improving laboratories and ...

The pharma will pay $200 million to buy Nimble and a preclinical oral drug that blocks a protein known as IL-23 — the target ...

Well before Roche said it would buy out its CAR-T partner Poseida Therapeutics for $1 billion upfront, another undisclosed ...

The European Medicines Agency (EMA) has approved Roche’s Vabysmo (faricimab) in single-dose prefilled syringe form for three ...

Roche (RHHBY) announced that the European Medicines Agency, EMA, has approved Vabysmo 6.0 mg single-dose prefilled syringe, ...

Roche (RHHBY) announced the CE certification of the new cobas 6800/8800 systems 2.0. The company said the new cobas 6800/8800 systems ...

AbbVie is paying $200 million to snap up Nimble Therapeutics, a Roche spinout working to develop oral peptide treatments in the autoimmune space. | AbbVie is paying $200 million to snap up Nimble ...

Roche’s new and updated molecular cobas 6800/8800 systems receives CE certification: Basel Saturday, December 14, 2024, 15:00 Hrs [IST] Roche announced the CE certification of t ...

Roche (RHHBY) announced the CE certification of the new cobas 6800/8800 systems 2.0. The update significantly enhances the efficiency of ...

Chicago’s Cour Pharmaceuticals—recently honored as one of Fierce Biotech’s 2024 Fierce 15—is bringing its immunology mission ...

Five years ago, I asked my boyfriend to move five hours from where we had lived our entire lives to a railroad town in ...